Influence of long term silicone implantation on type II collagen induced arthritis in mice

Annals of the Rheumatic Diseases

Volumn 58, Issue 8, 1999, Pages 503-509

  Schaefer, Caralee J ^a   Lawrence, W Dwayne ^a   Wooley, Paul H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN ANTIBODY; COLLAGEN TYPE 2; FREUND ADJUVANT; SILASTIC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; HISTOPATHOLOGY; IMMUNIZATION; IMMUNOPATHOGENESIS; INCIDENCE; LONG TERM EXPOSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REACTIVE ARTHRITIS; SARCOMA; SILICONE PROSTHESIS;

EID: 0032788612     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.58.8.503     Document Type: Article

References (38)

1. 1 Sanchez-Guerrero J, Colditz GA, Karlson EW, Hunter DJ, Speizer FE, Liang MH. Silicone breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med 1995;332:1666-70.
2. 2 Cuellar ML, Scopelitis H, Tenenbaum SA, Garry RF, Silveira LH, Cabrera G, et al. Serum antinuclear antibodies in women with silicone breast implants. J Rheumatol 1995; 22:236-40.
3. 3 Wooley PH, Luthra HS, Stuart JM, David CS. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 1981;154;688-700.
4. 4 Wooley PH. Collagen-induced arthritis in the mouse. Methods Enzymol 1988;162:361-73.
5. 5 Bliven ML, Wooley PH, Pepys MB, Ouerness IG. Murine type II collagen arthritis. Association of an acute-phase response with clinical course. Arthritis Rheum 1986;29: 1131-8.
6. 6 Horn JT, Bendele AM, Carlson DG. In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice. J Immunol 1988;141:834-41.
7. 7 Killar LM, Dunn CJ. Interleukin-1 potentiates the development of collagen-induced arthritis in mice. Clin Sci 1989; 76:535-8.
8. 8 Cooper SM, Sriram S, Ranges GE. Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-gamma. J Immunol 1988;141:1958-62.
9. 9 Cooper WO, Fava RA, Gates CA, Cremer MA, Townes AS, Acceleration of onset of collagen-induced arthritis by intraarticular injection of tumour necrosis factor or transforming growth factor-beta. Clin Exp Immunol 1992;89:244 50.
10. 10 Brahn E, Peacock DJ, Banquerigo ML, Liu DY. Effects of tumor necrosis factor alpha (TNF-alpha) on collagen arthritis. Lymphokine and Cytokine Research 1992;11: 253-6.
11. 11 Wooley PH, Scibold JR, Whalen JD, Chapdelaine JM. Pristane-induced arthritis. The immunologic and genetic features of an experimental murine model of autoimmune disease. Arthritis Rheum 1989;32:1022-30.
12. 12 Holmdahl R, Jansson L, Andersson M, Jonsson R. Genetic, hormonal and behavioural influence on spontaneously developing arthritis in normal mice. Clin Exp Immunol 1992;88:467-72.
13. 13 Schaefer CJ, Whalen JD, Knapp T, Wooley PH. The influence of silicone implantation on type II collagen-induced arthritis in mice. Arthritis Rheum 1997;40:1064 72.
14. 14 Sanchez-Guerrero J, Schur PH, Sergent JS, Liang MH. Silicone breast implants and rheumatic disease. Clinical, immunologic, and epidemiologic studies. Arthritis Rheum 1994;37:158-68.
15. 15 Finegold I. Allergy to silicone: is it real? Compr Ther 1996; 22:393-8.
16. 16 Solomon G. A clinical and laboratory profile of symptomatic women with silicone breast implants. Semin Arthritis Rheum 1994;24:29-37.
17. 17 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 1970;227:680-5.
18. 18 Kessler DA. The basis of the FDA's decision on breast implants. N Engl J Med 1992;326;1713-15.
19. 19 Duffy DM. Silicone: a critical review. Adv Dermatol 1990;5:93-107.
20. 20 Hennekens CH, Lee I, Cook NR, Herbert NR, Karlson EW, LaMotte F. et al. Self-reported breast implants and connective tissue diseases in female health professionals. A retrospective cohort study. JAMA 1996;275:616-21.
21. 21 Ellis JS, Chain BM, Cooke A, Ibrahim MA, Katz DR. Adjuvant composition determines the induction of type II collagen-induced arthritis. Strand J Immunol 1992;36:49 50.
22. 22 Kasama T, Strieter RM, Lukacs NW, Lincoln PM, Burdick MD, Kunkel SL. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest 1995;95:2868-76.
23. 23 Walmsley M, Katsikis PD, Abney E, Parry S, Williams RO, Maini RM, et al. Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum 1996;39:495-503.
24. 21 Stein SH, Hart TE, Huffman WH, Hendrix CL, Gustke CJ, Watson SC. Interleukin-10 promotes anti-collagen antibody production in type I diabetic peripheral B lymphocytes. J Periodontal Res 1997;32:189-95.
25. 25 Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995; 181:839-44.
26. 26 Krams SM, Cao S, Hayashi M, Villanueva JC, Martinez OM. Elevations in IFN-gamma, IL-5, and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: association with autoantibodies and soluble CD30. Clin Immunol Immunopathol 1996;80;311-20.
27. 27 Fuss IJ, Strober W, Dale JK, Fritz S, Pearlstein GR, Puck JM, et al. Characteristic T helper 2 T tell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity. J Immunol 1997;158:1912-18.
28. 28 Tenenbaum SA, Rice JC, Espinoza LR, Cuellar ML, Plymale DR, Sander DM, et al. Use of antipolymer antibody assay in recipients of silicone breast implants. Lancet 1997;349:449-54.
29. 29 Teuher SS, Rowley MJ, Yoshida SH, Ansari AA, Gershwin ME. Anti-collagen autoantibodies are found in women with silicone breast implants. J Autoimmun 1993;6:367-77.
30. 30 Rowley MJ, Cook AD, Teuber SS, Gershwin ME. Antibodies to collagen: comparative epitope mapping in women with silicone breast implants, systemic lupus erythematosus and rheumatoid arthritis. J Autoimmun 1994;7:775-89.
31. 31 Kossovsky N, Stassi J. A pathophysiological examination of the biophysics and bioreactivity of silicone breast implants. Semin Arthritis Rheum 1994;24:18-21.
32. 32 Thomassen MJ, Buoen LC, Brand I, Brand KG. Foreignbody tumorigenesis in mice: DNA synthesis in surface-attached cells during preneoplasia. J Natl Cancer Inst 1978;61:359-63.
33. 33 Brand I, Buoen LC, Brand KG. Foreign-body tumors of mice: strain and sex differences in latency and incidence. J Natl Cancer Inst 1977;58:1443-7.
34. 34 Brand KG, Brand I. Risk assessment of carcinogenesis at implantation sites. Plast Reconstr Surg 1980;66:591-5.
35. 35 James SJ, Pogribna M, Miller BJ, Bolon B, Muskhelishvili L. Characterization of cellular response to silicone implants in rats: implications for foreign-body carcinogenesis. Biomaterials 1997;18:667-75.
36. 36 Anonymous. Concerning experimental animal tumors associated with silicone gel. Dow Corning CorporationColorado Medicine 1988;85:486-6.
37. 37 Noone RB. A review of the possible health implications of silicone breast implants. Cancer 1997;79:1747-56.
38. 38 Engel A, Lamm SH, Lai SH. Human breast sarcoma and human breast implantation: a time trend analysis based on SEER data (1973 1990). J Clin Epidemiol 1995;48:539 44.